Natural product-based therapy for ageing-associated diseases: A therapeutic mix encompassing β-cryptoxanthin, Oleanolic acid and Withaferin A (β-COW), isolated from Sweet peppers/Papaya, Olive oil, Ashwagandha, respectively, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 6/October/2017, 1.16 am

Natural product-based PD-1 pathway activation for Pain therapy: Silymarin, isolated from M.Thistle, increases the expression of PD-L1, attenuates acutes and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability via up-regulation of its target gen, 06/October/2017, 1.03 am
October 5, 2017
Natural product-derived regenerative therapy for reversing diabetes: A pharmaceutical mixture encompassing Celastrol, Mangiferin, Omega-3, Taurine, & Vit-D/C/E (CMOTV-DCE) increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D via down regulation of its target gene, 6/October/2017, 1.27 am
October 5, 2017
Show all

Introduction: What they say

A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School of Medical Sciences, The University of New South Wales, Sydney, New South Wales 2052, Australia shows that “A conserved NAD+ binding pocket that regulates protein-protein interactions during aging.” This research paper was published in the 24 March 2017 issue of the journal “Science” [One of the best research journals in Science with an I.F of 34+] by Prof. David A. Sinclair, Jun Li and others.


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Natural product-based therapy for ageing-associated diseases: A therapeutic mix encompassing β-cryptoxanthin, Oleanolic acid and Withaferin A (β-COW), isolated from Sweet peppers/Papaya, Olive oil, Ashwagandha, respectively, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene

Price 500[easy_payment currency=”USD”]


What is known?

Prof. David A. Sinclair’s research team has recently shown that: (a) increased levels of NAD+ (found in non-aged tissues) inhibits the interaction the between DBC1 (deleted in breast cancer 1) and PARP1 [poly(adenosine diphosphate–ribose) polymerase]; and promotes DNA repair; (b) decreased levels of NAD+ (found in aged tissues) promotes the interaction between DBC1 and PARP1 and inhibits DNA repair; (c) aged cells/tissues that are low in NAD+ are radiation-sensitive, cancer-prone and prone to accelerated ageing; and (d) ageing-associated diseases can be reversed by increasing the concentration of NAD+ in ageing tissues, suggesting that ageing-associated diseases, in part, can be reversed by NAD+ supplementation in older animals.


From research findings to therapeutic opportunity:

This study suggests, for the first time, a natural product-based therapy for age-associated diseases.

A therapeutic mix encompassing β-cryptoxanthin, Oleanolic acid and Withaferin A (β-COW), by increasing the expression of its target gene, it may increase the levels of NAMPT and NMN/NAD+. Thereby, it may: (1) increase plasma NMN levels and tissue NAD+ availability; (2) inhibit the interaction between DBC1 and PARP1; (3) augment PARP1’s DNA repair activity; (4) protect against radiation; (5) protect against cancer; and (6) prevent age-associated gene expression pattern and accelerated ageing.

Figure1. A therapeutic mix encompassing βcryptoxanthin, Oleanolic acid and Withaferin A (β-COW), by increasing NAD+ levels, may suppress ageing-associated overall physiological decline, ageing-associated diseases and improve health/life span

 

Thus, pharmacological formulations encompassing “β-cryptoxanthin, Oleanolic acid and Withaferin A (β-COW) or their analogues, either alone or in combination with other drugs,” may be used to suppress age-associated overall physiological decline and improve health/life span.[easy_payment currency=”USD”]


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How a therapeutic mix encompassing β-cryptoxanthin, Oleanolic acid and Withaferin A (β-COW) increases the levels of NMN/NAD to inhibit interaction between DBC1 and PARP1 and to promote DNA repair activity

Amount: $500#

* Research cooperation

For purchase and payment details, you may reach us at info@genomediscovery.org


References:

Citation: Boominathan, L., Natural product-based therapy for ageing-associated diseases: A therapeutic mix encompassing β-cryptoxanthin, Oleanolic acid and Withaferin A (β-COW), isolated from Sweet peppers/Papaya, Olive oil, Ashwagandha, respectively, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 6/October/2017, 1.12 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or http://newbioideas.com

Courtesy: When you cite us, kindly drop us a line

Comments are closed.